Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1Phase 1/2 1

Status

Recruiting 4Not yet recruiting 1Completed 1

Sponsor Class

OTHER 6

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Carcinoma, Hepatocellular 15Esophageal Neoplasms 12Colorectal Neoplasms 9Stomach Neoplasms 6Rectal Neoplasms 6Esophageal Squamous Cell Carcinoma 6Pancreatic Neoplasms 5Neoplasms 4Liver Neoplasms 4Cholangiocarcinoma 4Neoplasm Metastasis 3Melanoma 3Carcinoma, Renal Cell 3Liver Diseases 2Gastrointestinal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Adenocarcinoma 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Unresectable Hepatocellular Carcinoma 1Unresectable Biliary Tract Cancer 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Thyroid Neoplasms 1

Interventions

Cisplatin 116Radiotherapy 84Paclitaxel 77Fluorouracil 62Carboplatin 41Drug Therapy 38pembrolizumab 33Irinotecan 33tislelizumab 27Docetaxel 26Neoadjuvant Therapy 24Oxaliplatin 23toripalimab 22sintilimab 19camrelizumab 19Radiation 19Esophagectomy 18Capecitabine 17130-nm albumin-bound paclitaxel 17Surgical Procedures, Operative 16Nivolumab 16Leucovorin 15Cetuximab 14TP protocol 12S 1 (combination) 12Radiotherapy, Intensity-Modulated 12Albumin-Bound Paclitaxel 12nimotuzumab 11apatinib 10Immune Checkpoint Inhibitors 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Immunotherapy × Gastrointestinal × Clear all
NCT05978193 2026-01-22

SCR-ESCC-01

Shanghai Chest Hospital

Phase 2 Recruiting
100 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT06907602 2025-04-02

ONTRESCC

Peking Union Medical College Hospital

Phase 2/3 Recruiting
120 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06190652 2024-02-05

REICRAE

Tianjin Medical University Cancer Institute and Hospital

Completed
728 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06173986 2023-12-18

Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer

Shanghai Chest Hospital

Phase 1/2 Recruiting
50 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05791136 2023-03-30

TREE

The Central Hospital of Lishui City

Phase 2 Not yet recruiting
30 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05507411 2022-08-19

WATCHER

Zhejiang Cancer Hospital

Phase 2 Recruiting
100 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡